What are Clinical Trials?
Clinical trials are medical research performed in people. Most clinical trials investigate whether a new medicine is safe and effective for the treatment of a medical condition. Though, some may also help our understanding of disease processes.
Apply to become a clinical trial volunteer and our team will find the right clinical trials for you.
Or browse and register your interest directly in one of our clinical trials below.
Our Clinical Trials
Safety, tolerability and pharmacokinetics investigation of GSK010224 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria Testing a drug for the treatment of Tuberculosis
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK110908 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male & Female
Age: 18 - 60 years
You will be compensated up to £7360 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria Testing a drug for the treatment of Tuberculosis
Duration: 17 nights in-house + screening & follow up
Sex: Male & Female
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK112425 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male & Female
Age: 18 - 60 years
You will be compensated up to £7360 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria Testing a drug for the treatment of Tuberculosis
Duration: 17 nights in-house + screening & follow up
Sex: Male & Female
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK19090923 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria Testing a drug for the treatment of Tuberculosis
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK200923 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria Testing a drug for the treatment of Tuberculosis
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK291124 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male & Female
Age: 18 - 60 years
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria Testing a drug for the treatment of Tuberculosis
Duration: 17 nights in-house + screening & follow up
Sex: Male & Female
Age: 18 - 60 years
Sample 8 series study
Duration: 3 months
Sex: Male & Female
Age: 18 - 55 years
You will be compensated up to £6000 for your time, plus reasonable travel expenses.
Tagline sample 8 series study
Duration: 3 months
Sex: Male & Female
Age: 18 - 55 years
Sample 999999 series study
Duration: 3 months
Sex: Male & Female
Age: 18 - 55 years
You will be compensated up to £5000 for your time, plus reasonable travel expenses.
Tagline sample 999999 series study
Duration: 3 months
Sex: Male & Female
Age: 18 - 55 years
Safety, tolerability and pharmacokinetics investigation of GSK2556586 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK2776586 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK2556286 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK2556286 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK2556286 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK2556286 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK110624 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male & Female
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria Testing a drug for the treatment of Tuberculosis
Duration: 17 nights in-house + screening & follow up
Sex: Male & Female
Age: 18 - 60 years
Test Study
Duration: N/A
Sex: N/A
Age: 0 - 0 years
Tagline with 150 characters Tagline with 150 characters Tagline with 150 characters Tagline with 150 characters Tagline with 150 characters Tagline 15
Duration: N/A
Sex: N/A
Age: 0 - 0 years
Safety, tolerability and pharmacokinetics investigation of GSK230123 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
You will be compensated up to £4400 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria Testing a drug for the treatment of Tuberculosis
Duration: 17 nights in-house + screening & follow up
Sex: Male
Age: 18 - 60 years
Safety, tolerability and pharmacokinetics investigation of GSK113708 in healthy adult participants.
Duration: 17 nights in-house + screening & follow up
Sex: Female
Age: 18 - 60 years
You will be compensated up to £7360 for your time, plus reasonable travel expenses.
Testing a new drug for the treatment of Tuberculosis (TB) An infectious disease caused by a bacteria Testing a drug for the treatment of Tuberculosis
Duration: 17 nights in-house + screening & follow up
Sex: Female
Age: 18 - 60 years
Lupus of the Skin
Sex: Male and Female
Age: 18+ years of age
You will be compensated for your time and commitment if you participate in a trial.
We are looking for people who are willing to take part in clinical trials to help develop new medicines for Lupus.
Sex: Male and Female
Age: 18+ years of age
Vaccines
Sex: Male and Female
Age: 18+ years of age
You will be compensated for your time and commitment if you participate in a trial.
We are looking for people who are willing to take part in vaccine clinical trials, most of which are outpatient.
Sex: Male and Female
Age: 18+ years of age
Lupus of the Skin
Duration: N/A
Sex: N/A
Age: 0 - 0 years
We are looking for people who are willing to take part in clinical trials to help develop new medicines for Lupus. We are looking for people who are..
Duration: N/A
Sex: N/A
Age: 0 - 0 years
More Trials coming soon!
We will be adding more Clinical Trials to our website soon. However, we are always looking for Clinical Trial volunteers. Apply now to register your interest in future Clinical Trials.
